LBA3 Final analysis of the phase III KEYNOTE-585 study of pembrolizumab plus chemotherapy vs chemotherapy as perioperative therapy in locally-advanced gastric and gastroesophageal junction cancer
Kohei Shitara(National Cancer Center Hospital East), Sun Young Rha(Yonsei University Health System), Lucjan Wyrwicz(The Maria Sklodowska-Curie National Research Institute of Oncology), Takashi Oshima(Kanagawa Prefectural Hospital Organization), Nina Karaseva(City Clinical Oncology Center), M. A. Osipov(Leningrad Regional Cancer Center), Haruna Yasui(Kobe City Medical Center General Hospital), Hiroshi Yabusaki(Niigata Cancer Center Hospital), S. G. Afanasyev, Park Yk(Chonnam National University Hwasun Hospital), S-E. Al-Batran(Goethe University Frankfurt), Takaki Yoshikawa(Tokyo National Hospital), P.E. Yanez Weber, Maria Di Bartolomeo(Fondazione IRCCS Istituto Nazionale dei Tumori), Sara Lonardi(Istituto Oncologico Veneto), X. Fang(Merck & Co., Inc., Rahway, NJ, USA (United States)), C-S. Shih(Merck & Co., Inc., Rahway, NJ, USA (United States)), P. Bhagia(Merck & Co., Inc., Rahway, NJ, USA (United States)), Y-J. Bang(Seoul National University)
Cited by 13Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis